Researchers Cast Doubt on Aspirin for Heart Attack Prevention
A pill a day won’t keep the doctor away. While aspirin’s blood-thinning properties cut heart attack risks for patients with established cardiovascular disease, new research shows little evidence that it benefits those who haven’t already suffered a myocardial infarction. The meta-analysis of 118,445 people from 11 cardiovascular disease prevention trials showed that while aspirin reduced risk by 22 percent, potential side effects like hemorrhaging and gastrointestinal bleeding outweighed that benefit. The study’s author recommends consulting with a doctor before deciding on a daily aspirin regimen.